Fukuyama, Japan

Kazumi Inohara

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Nihon Medi-Physics Company, Limited, Toyo Hakka Kogyo Co., Ltd.. Active years: 1989-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazumi Inohara. Retrieved from https://idiyas.com/inventor/kazumi-inohara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 41(Granted Patents)


Location History:

  • Hiroshima, JP (1989)
  • Fukuyama, JP (1991)

Company Filing History:


Years Active: 1989-1991

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazumi Inohara: Innovator in Porphyrin Derivatives

Introduction

Kazumi Inohara is a notable inventor based in Fukuyama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of porphyrin derivatives. His work has implications for medical applications, especially in cancer treatment.

Latest Patents

Kazumi Inohara holds 2 patents related to porphyrin compounds. His latest patents include innovative formulations that demonstrate high accumulation in cancerous tissues while allowing for quick excretion from normal tissues. These compounds are designed to enhance the effectiveness of cancer therapies.

Career Highlights

Throughout his career, Inohara has worked with prominent companies such as Nihon Medi-Physics Company, Limited and Toyo Hakka Kogyo Co., Ltd. His experience in these organizations has contributed to his expertise in the field of chemical innovations.

Collaborations

Inohara has collaborated with notable colleagues, including Isao Sakata and Susumu Nakajima. These partnerships have fostered a collaborative environment that has led to advancements in their respective fields.

Conclusion

Kazumi Inohara's contributions to the field of porphyrin derivatives highlight his innovative spirit and dedication to advancing medical science. His work continues to influence cancer treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…